Related News
Researchers in heart-attack warning
PEOPLE who suffer a heart attack nearly double the risk of another if they take blood thinner Plavix with a heartburn drug such as Prilosec, researchers said yesterday.
Plavix and aspirin are often used to thin a patient's blood after a heart attack.
Doctors also may prescribe a proton pump inhibitor, or PPI, such as Prilosec to cut the risk of intestinal bleeding.
A study published in the Journal of the American Medical Association tracked 8,205 patients in the United States given Plavix and aspirin.
Two-thirds also took a PPI, primarily Prilosec, and had almost double the risk of another heart attack compared to those not taking a PPI, Dr Michael Ho, of the Denver VA Medical Center, said.
Other doctors urged caution. "We have to be really careful with this study," said Dr Kirk Garratt of Lenox Hill Hospital in New York. "If we stop prescribing PPIs, we will see more bleeding complications."
Plavix and aspirin are often used to thin a patient's blood after a heart attack.
Doctors also may prescribe a proton pump inhibitor, or PPI, such as Prilosec to cut the risk of intestinal bleeding.
A study published in the Journal of the American Medical Association tracked 8,205 patients in the United States given Plavix and aspirin.
Two-thirds also took a PPI, primarily Prilosec, and had almost double the risk of another heart attack compared to those not taking a PPI, Dr Michael Ho, of the Denver VA Medical Center, said.
Other doctors urged caution. "We have to be really careful with this study," said Dr Kirk Garratt of Lenox Hill Hospital in New York. "If we stop prescribing PPIs, we will see more bleeding complications."
- About Us
- |
- Terms of Use
- |
- RSS
- |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 沪ICP证:沪ICP备05050403号-1
- |
- 互联网新闻信息服务许可证:31120180004
- |
- 网络视听许可证:0909346
- |
- 广播电视节目制作许可证:沪字第354号
- |
- 增值电信业务经营许可证:沪B2-20120012
Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.